What are the opening hours?

Monday 6am - 4pm Tuesday 6am - 4pm Wednesday 6am - 4pm Thursday 6am - 4pm Friday 6am - 4pm

Oasis Diagnostics Corporation

Home
United States
Portland, OR
Oasis Diagnostics Corporation

Call Directions Website Contact the practice

Non-invasive saliva based technology for rapid testing, sample collection & molecular diagnostics

Oasis Diagnostics® Corporation was founded to address a growing need for non-invasive saliva based technology for rapid testing, sample collection, and molecular diagnostics.

10/13/2026

A simple saliva sample may one day help identify oral cancer risk earlier—especially among people who use to***co.

A recent pilot study highlighted by Bioengineer examined salivary microRNAs (miRNAs) together with cell-based markers such as EGFR and p53 as potential noninvasive biomarkers for oral squamous cell carcinoma. Researchers studied 40 participants across oral cancer patients, to***co users without cancer, and healthy controls.

One of the strongest findings involved miR-31-5p, which was elevated in saliva from both to***co users and oral cancer patients. EGFR expression in exfoliated oral cells also increased across these groups, suggesting that a combined biomarker approach may be more informative than relying on a single marker alone.

For Oasis Diagnostics®, research like this reinforces the growing potential of saliva as an accessible, noninvasive specimen for biomarker discovery and future screening applications. It also highlights the importance of reliable collection tools such as Pure•SAL™ and RNAPro•SAL™ [Pure•SAL™ shown], which can support saliva collection for RNA-focused research and downstream molecular analysis.

As interest in salivary miRNAs continues to grow, technologies that help enable dependable saliva collection may play an important role in advancing biomarker research and future diagnostic development.

The findings are still preliminary—the study involved only 40 participants and will require validation in larger, independent populations before any clinical application.

Read the full article:
https://bioengineer.org/spit-test-for-oral-cancer-saliva-mirnas-and-cell-markers-show-promise-in-to***co-users/

10/12/2026

A newborn can pass a hearing screening and still be at risk for hearing loss associated with congenital cytomegalovirus (CMV).

A recent Cleveland.com article highlights an important distinction: newborn hearing screening checks hearing at that moment, while CMV testing determines whether the infection was acquired before birth. These tests answer different questions—and timing matters.

According to the article, congenital CMV must generally be confirmed using samples collected within the first 2–3 weeks after birth. The standard laboratory approach begins with saliva testing, followed by urine testing for confirmation. Because breast milk can contain CMV, saliva collection should take place more than an hour after breastfeeding to help reduce the risk of a false-positive result.

For babies with confirmed congenital CMV, continued hearing monitoring is important because CMV-related hearing loss may appear later in infancy or childhood, even after a newborn initially passes hearing screening.

For Oasis Diagnostics®, this is another example of the important role saliva can play in early-life testing. Reliable, noninvasive saliva collection can help support timely diagnostic workflows when the testing window is especially important.

Early testing and continued hearing monitoring serve different purposes—but together, they can help provide a clearer picture of a child’s health over time.

Read the full article:
https://www.cleveland.com/metro/2026/10/what-we-learned-about-newborn-hearing-screening-and-cmv-related-hearing-loss.html

10/09/2026

I am deeply honored and proud to share that our e-book, “Biofluid Biomarkers for the Diagnosis of Neurodegenerative Diseases: Current Status,” has officially been published by Frontiers in Neuroscience!

This publication represents an exciting milestone and the culmination of months of collaboration, research, and dedication.

The e-book brings together 12 published scientific articles, exploring the rapidly evolving field of biofluid biomarkers and their potential role in the diagnosis of neurodegenerative diseases.

The collection covers a diverse range of biological specimens, including cerebrospinal fluid (CSF), plasma, whole blood, saliva, and exosomes, highlighting the breadth of research and scientific progress in this important area.

I would like to express my sincere gratitude to my fellow co-editors, Dr. Boris Decourt, Dr. Marwan Sabbagh, and Dr. Michelle Mielke, for their invaluable contributions, expertise, and collaboration throughout this project. It has been a privilege to work alongside such distinguished colleagues.

I am also grateful to all the researchers and authors whose contributions made this collection possible.

What makes this publication even more meaningful is that the entire e-book is OPEN ACCESS and available as a FREE download to anyone interested in exploring the research and insights presented in these articles.

I warmly invite my colleagues, fellow researchers, and anyone interested in neurodegenerative diseases and biomarker research to explore the collection.

📖 Access the e-book here:
https://www.frontiersin.org/research-topics/69758/biofluid-biomarkers-for-the-diagnosis-of-neurodegenerative-diseases-current-status/magazine?%24web_only=true&_branch_match_id=1633498622092690081&_branch_referrer=H4sIAAAAAAAAAwXBQQqAMAwEwB%2B1d0GE3gT%2FIEq3NlQT2VS8%2BXZnau%2B3DzEWWtAuoAfRmMTK%2BUhOYtfGBjqSWZs%2BooAUPdad9jo4LqINedYfREUHJUkAAAA%3D

10/07/2026

A lollipop that can test medication levels in saliva? That’s exactly what researchers behind Lollylab are exploring.🍭

The candy-coated prototype is designed to both collect saliva and measure acetaminophen directly at the point of care. In an initial proof-of-concept study, six adults used the device before and after taking acetaminophen, and the system reliably detected the medication in saliva in less than two minutes.

What makes this especially interesting is the design. The peach-flavored candy coating stimulates saliva production, saliva moves through the device toward a graphene sensor, and the sensor measures acetaminophen levels through changes in electrical current.

Participants also reported that the device was easier and more comfortable to use than traditional saliva collection swabs.

For Oasis Diagnostics®, developments like this highlight the continued growth of saliva as a practical, noninvasive specimen for diagnostic and monitoring applications. As researchers develop new ways to combine sample collection and testing into a single platform, reliable saliva collection remains an important part of making these technologies practical.

The researchers now plan to explore additional biomarkers, including naturally occurring stress markers, with the longer-term goal of developing a multi-assay saliva testing platform.

Read the full article:
https://www.eurekalert.org/news-releases/1146501

10/06/2026

AI is opening new possibilities for predicting disease earlier—and saliva may play an important role in that future.

Professor Eiryo Kawakami of Chiba University is researching how artificial intelligence and machine learning can be combined with minimally invasive, everyday measurement methods, including wearable devices and saliva-based testing, to support earlier disease detection and prediction.

His team is exploring how AI can analyze complex biological patterns rather than relying on a single marker. One area of research involves detecting early signs of disease by examining data from devices such as smartwatches and smart glasses alongside molecules found in saliva.

This approach reflects an important shift toward more continuous, data-driven healthcare—where multiple biological and behavioral signals can be analyzed together to help identify risk earlier and potentially guide prevention and treatment.

At Oasis Diagnostics®, this is especially relevant to our work in saliva collection. Reliable, noninvasive saliva sampling can help support the kinds of research needed to better understand biomarkers, disease progression, and the future of AI-enabled diagnostics.

The combination of saliva, wearable technology, and AI could become an important part of how health is monitored and understood over time.

Read more:
https://www.eurekalert.org/news-releases/1145832

10/05/2026

A new graphene-based sensor could make saliva-based stress monitoring faster and more accessible.

Researchers have developed an electrolyte-gated graphene transistor capable of detecting cortisol—the body’s primary stress hormone—directly from human saliva, with results available in about 7 minutes. The sensor was also compared with conventional ELISA testing and showed close agreement at lower cortisol concentrations. Graphene Info

This is another compelling example of how saliva is emerging as a valuable diagnostic specimen. Its noninvasive collection and potential compatibility with rapid, portable technologies could help move certain types of testing beyond traditional laboratory settings.

At Oasis Diagnostics®, we are focused on enabling reliable and practical saliva collection for researchers and diagnostic developers and a number of our customers utilize Oasis Devices [Super•SAL™, Pure•SAL™-C] for cortisol detection and quantfication.

As technologies like graphene biosensors continue to advance, the combination of innovative detection platforms and effective saliva collection could open new possibilities for real-time biomarker monitoring and point-of-care diagnostics.

Read the full article:
https://www.graphene-info.com/graphene-sensor-detects-stress-hormone-cortisol-saliva-within-minutes

10/02/2026

Women carry a disproportionate burden of oral disease—and new research suggests that burden could continue to grow.

A recent article from DrBicuspid highlights the significant oral health challenges facing women, particularly postmenopausal women. The reported global burden is already substantial, underscoring the importance of better prevention, earlier identification of oral health changes, and accessible approaches to monitoring health.

This is also an important reminder of the value of saliva as a biological specimen. Saliva provides a convenient, noninvasive way to collect biological information and continues to attract interest across oral and systemic health research.

At Oasis Diagnostics®, our focus is making saliva collection simple, reliable, and practical—helping researchers and healthcare innovators explore the growing potential of saliva-based testing.

As our understanding of the relationship between oral health, aging, hormones, and overall health continues to evolve, saliva may have an increasingly important role to play.

Read the DrBicuspid article:
https://www.drbicuspid.com/dental-practice/public-health/vulnerable-populations/article/15835585/women-carry-the-oral-disorder-burden-and-it-may-get-worse

09/29/2026

The future of pet health may begin with a simple sample of saliva. 🐾

Pet DNA testing has rapidly evolved from a niche curiosity into an important tool for understanding our companion animals. Today, pet owners use genetic testing to learn about breed ancestry, inherited traits, and potential health risks, supporting more informed decisions around preventive care and wellness.

A key driver of this field's growth is the simplicity of sample collection. Unlike more invasive approaches, saliva and cheek swab samples provide a convenient way to access valuable biological information while ensuring a comfortable experience for pets and their owners.

At Oasis Diagnostics, we believe saliva has enormous potential beyond human healthcare, including the world of animal health. Our Micro•SAL™ for Animals technology is designed to enable gentle, reliable saliva collection, helping researchers, veterinary professionals, and animal health companies obtain high-quality samples for genetic testing, biomarker research, and future diagnostic applications.

As veterinary medicine moves toward preventive and personalized care, accessible sample collection will play an increasingly important role. Saliva offers the opportunity to make testing easier, less stressful, and more practical for companion animals.

From understanding a pet’s genetic story to supporting earlier insights into health, saliva is opening new possibilities in animal wellness. The Saliva Movement is not just transforming human diagnostics, it is helping create a healthier future for our animals, too. 🐶🐱

You can read more here: https://www.pressreader.com/usa/the-signal/20260926/281934549870638

09/28/2026

What if one of the most important tests a newborn receives could be made gentler?

Newborn screening has transformed the way we identify serious health conditions early in life. However, many current newborn screening programs still require collecting blood through a heel stick — a procedure that can be uncomfortable for the infant and an emotional moment for parents watching their baby being tested.
A recent study highlighted by EurekAlert! demonstrates the growing potential of saliva-based newborn screening for detecting congenital cytomegalovirus (cCMV), one of the most common congenital infections.

The study evaluated saliva testing in 48,556 newborns, identifying infants with cCMV who may not have shown symptoms at birth. The findings highlight how saliva-based approaches could help expand early detection in a way that is simple and non-invasive.

At Oasis Diagnostics, we believe technologies like Micro•SAL™ have the potential to play an important role in this future.

Designed for gentle and reliable saliva collection, Micro•SAL™ provides a simple way to collect valuable biological samples from even our youngest patients. By enabling saliva collection instead of relying solely on more invasive collection methods, Micro•SAL™ represents our commitment to making diagnostics easier, more comfortable, and more patient-friendly.

For parents, every moment matters — especially in the first days of a newborn’s life. The ability to gather important health information through a gentle saliva collection approach could help create a better experience for babies, families, and healthcare providers.

The future of newborn screening is not only about detecting disease earlier.
It is also about creating a kinder experience from the very beginning.

And it may start with saliva.

Read more:
https://www.eurekalert.org/news-releases/1145351

09/25/2026

The future of healthcare may begin with something we have always taken for granted — saliva.

I was excited to see Melissa Turner and Women in DSO highlight the growing Saliva Movement and the incredible potential of saliva-based diagnostics in transforming the future of dentistry and healthcare.

For decades, saliva has been overlooked as a diagnostic specimen. Today, advances in molecular science are showing us that saliva is a powerful source of biological information — offering a simple, non-invasive way to detect and monitor important health signals.

At Oasis Diagnostics, our mission has always been to unlock the potential of saliva through innovative collection technologies and biomarker solutions. From oral health to systemic diseases, saliva has the opportunity to make testing more accessible, patient-friendly, and integrated into routine care.

The movement toward saliva-based diagnostics is not just about replacing traditional methods — it is about creating new possibilities for earlier detection, personalized care, and a more proactive approach to health.

A special thank you to Women in DSO for shining a light on this important shift and recognizing the role saliva can play in the future of dentistry.

The future of diagnostics is closer than we think — and it may start with a simple drop of saliva.

Read more:
https://womenindso.org/ -blog/f/saliva-movement-were-suctioning-away-the-future-of-dentistry

Address

5920 NE 112th Avenue
Portland, OR
97220

Opening Hours

Monday	6am - 4pm
Tuesday	6am - 4pm
Wednesday	6am - 4pm
Thursday	6am - 4pm
Friday	6am - 4pm

Telephone

+13605461563

Website

http://www.4saliva.com/

Alerts

Be the first to know and let us send you an email when Oasis Diagnostics Corporation posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Oasis Diagnostics Corporation:

Want your practice to be the top-listed clinic in Portland?